← FDA DRUG APPROVALS

FDA NDA · NDA018933

M.V.I.-12 LYOPHILIZED

Sponsor: TELIGENT

APPLICATION
NDA018933
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

M.V.I.-12 LYOPHILIZEDDiscontinued
ASCORBIC ACID 100MG/VIAL, BIOTIN 0.06MG/VIAL, CYANOCOBALAMIN 0.005MG/VIAL, DEXPANTHENOL 15MG/VIAL, ERGOCALCIFEROL 5MCG/VIAL, FOLIC ACID 0.4MG/VIAL, NIACINAMIDE 40MG/VIAL, PYRIDOXINE 4MG/VIAL, RIBOFLAVIN 5'-PHOSPHATE SODIUM 3.6MG/VIAL, THIAMINE 3MG/VIAL, VITAMIN A 1MG/VIAL, VITAMIN E 10MG/VIAL · INJECTABLE · INJECTION
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →